Ingersoll Rand Expands Life Sciences Solutions with Acquisition of IVEK Corporation

• Expands life sciences portfolio through expertise in key precision pump technologies and solutions, adding approximately $40 million in annual revenue
• Increases ability to offer solutions requiring small-volume precision liquid metering and dispensing systems
• Adds another family-owned company to the Ingersoll Rand portfolio
• Investment made at attractive low-double digit pre-synergy purchase multiple of 2025 Adjusted EBITDA

DAVIDSON, N.C.--(BUSINESS WIRE)--#MakingLifeBetter--Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired IVEK Corporation, expanding the company’s life sciences portfolio.

Based in the United States, IVEK is a leading designer and manufacturer of small-volume precision liquid metering and dispensing systems with expertise in precision fluid control, primarily serving the healthcare, diagnostics, medical device and biomedical industries. The company specializes in critical applications where volumetric accuracy, repeatability, and long-term reliability directly impact a customer’s product quality, regulatory compliance, and patient safety.

IVEK’s engineering expertise and innovations, including fluidic systems and components, ceramic positive-displacement technology, and OEM integration capabilities, along with aftermarket services, enhance Ingersoll Rand’s abilities to offer key precision pump technologies and solutions for life sciences customers. The acquisition will join the Life Sciences platform within the Precision and Science Technologies (P&ST) segment.

“The addition of IVEK to Ingersoll Rand meaningfully expands our life sciences capabilities in precision liquid metering and dispensing,” said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand. “Their engineering and manufacturing expertise in a variety of applications and key industries will help us better serve customers in these areas where high-performance, customizable solutions are essential. We look forward to welcoming IVEK to the family.”

About Ingersoll Rand Inc.

Ingersoll Rand Inc. (NYSE: IR), driven by an entrepreneurial spirit and ownership mindset, is dedicated to Making Life Better for our employees, customers, shareholders, and planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life science and industrial solutions. Supported by over 80+ respected brands, our products and services excel in the most complex and harsh conditions. Our employees develop customers for life through their daily commitment to expertise, productivity, and efficiency. For more information, visit IRCO.com.

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to the expectations of Ingersoll Rand Inc. (the “Company” or “Ingersoll Rand”), regarding the performance of its business, its financial results, its liquidity and capital resources and other non-historical statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “on track to,” “will continue,” “will likely result,” “guidance” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements other than historical facts are forward-looking statements.

These forward-looking statements are based on Ingersoll Rand’s current expectations and are subject to risks and uncertainties, which may cause actual results to differ materially from these current expectations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. The inclusion of such statements should not be regarded as a representation that such plans, estimates, or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) adverse impact on our operations and financial performance due to geopolitical tensions, natural disaster, catastrophe, cyber events, or other events outside of our control; (2) unexpected costs, charges, or expenses resulting from completed and proposed business combinations; (3) uncertainty of the expected financial performance of the Company; (4) failure to realize the anticipated benefits of completed and proposed business combinations; (5) the ability of the Company to implement its business strategy; (6) difficulties and delays in achieving revenue and cost synergies; (7) inability of the Company to retain and hire key personnel; (8) evolving legal, regulatory, and tax regimes; (9) changes in general economic and/or industry specific conditions; (10) actions by third parties, including government agencies; and (11) other risk factors detailed in Ingersoll Rand’s most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”), as such factors may be updated from time to time in its periodic filings with the SEC, which are available on the SEC’s website at http://www.sec.gov. The foregoing list of important factors is not exclusive.

Any forward-looking statements speak only as of the date of this release. Ingersoll Rand undertakes no obligation to update any forward-looking statements, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.

Investor Relations:
Max.Vorcheimer@irco.com

Media:
Jamie.Newman@irco.com